AdHER2.1
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AdHER2.1, covering 2012-06-04 to 2012-06-04. Get the full timeline:
Most recent: Clinical Trial Update: Adenovirus Encoding Rat HER-2 in Patients With Metastatic Breast Cancer (AdHER2.1) [Phase 1]